325®
EST. 1995 NY · NJ
FIG. 02 / AERAMI THERAPEUTICS

Inhaled therapeutics, made legible.

Brand identity, narrative video, and educational systems for a company building inhaled biologics. We translated mechanism into metaphor without losing the underlying truth.

Client
Aerami Therapeutics
Sector
Pulmonary
Category
Biotech
FIG. 02.A / Image to be supplied
FIG. 02.A / Aerami Therapeutics brand application. Photography in production.

Aerami Therapeutics develops improved therapies for severe respiratory diseases. Lead asset: inhaled imatinib (AER-901) for pulmonary arterial hypertension.

They needed a rebrand and a way to educate stakeholders on a proprietary inhalation technology that most investors and clinicians were encountering for the first time.

We infused elements of Aerami technology into the brand identity itself. The logo incorporates air. The visual system carries an airy, light tone, feel, typography, and palette that physically resembles the act of inhalation.

The website was built to address multiple audiences without splitting them: investors, clinicians, and patients each had a path through the same material.

A complete corporate identity, website, and brand guidelines. Stationery system for medical and investor channels.

A corporate video concepted, storyboarded, scripted, cast, shot, and edited in under three weeks. Built to explain the inhalation technology in 90 seconds.

"

The logo itself incorporates air into the brand.

325 / Aerami case file
FIG. 02.B / Corporate video delivery
03wk

Concepted, storyboarded, scripted, cast, shot, and edited in under three weeks. Most agencies would still be in pre-production.

325 / Aerami / Video delivery 2022
Capabilities applied
§ 09   Engagement

Begin a conversation.

Sixty minutes. No deck. We ask about your science, your audiences, and what your last agency got wrong.

Begin a conversation